206 related articles for article (PubMed ID: 38657866)
1. Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity.
Cao Z; Hou Y; Zhao Z; Zhang H; Tian L; Zhang Y; Dong C; Guo F; Tan L; Han Y; Wang W; Jiao S; Tang Y; An L; Zhou Z
J Biol Chem; 2024 Apr; 300(6):107311. PubMed ID: 38657866
[TBL] [Abstract][Full Text] [Related]
2. Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer.
Tang Y; Fang G; Guo F; Zhang H; Chen X; An L; Chen M; Zhou L; Wang W; Ye T; Zhou L; Nie P; Yu H; Lin M; Zhao Y; Lin X; Yuan Z; Jiao S; Zhou Z
Cancer Cell; 2020 Jul; 38(1):115-128.e9. PubMed ID: 32589942
[TBL] [Abstract][Full Text] [Related]
3. Cryo-EM structure of the Hippo signaling integrator human STRIPAK.
Jeong BC; Bae SJ; Ni L; Zhang X; Bai XC; Luo X
Nat Struct Mol Biol; 2021 Mar; 28(3):290-299. PubMed ID: 33633399
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers.
An L; Cao Z; Nie P; Zhang H; Tong Z; Chen F; Tang Y; Han Y; Wang W; Zhao Z; Zhao Q; Yang Y; Xu Y; Fang G; Shi L; Xu H; Ma H; Jiao S; Zhou Z
J Clin Invest; 2022 May; 132(9):. PubMed ID: 35290241
[TBL] [Abstract][Full Text] [Related]
5. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
6. SPTAN1/NUMB axis senses cell density to restrain cell growth and oncogenesis through Hippo signaling.
Su D; Li Y; Zhang W; Gao H; Cheng Y; Hou Y; Li J; Ye Y; Lai Z; Li Z; Huang H; Li J; Li J; Cheng M; Nian C; Wu N; Zhou Z; Xing Y; Zhao Y; Liu H; Tang J; Chen Q; Hong L; Li W; Peng Z; Zhao B; Johnson RL; Liu P; Hong W; Chen L; Zhou D
J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37843276
[TBL] [Abstract][Full Text] [Related]
7. Architecture, substructures, and dynamic assembly of STRIPAK complexes in Hippo signaling.
Tang Y; Chen M; Zhou L; Ma J; Li Y; Zhang H; Shi Z; Xu Q; Zhang X; Gao Z; Zhao Y; Cheng Y; Jiao S; Zhou Z
Cell Discov; 2019; 5():3. PubMed ID: 30622739
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.
Wang T; Wang D; Sun Y; Zhuang T; Li X; Yang H; Zang Y; Liu Z; Yang P; Zhang C; Cui J; Fu M; Zhang S; Su P; Li Z; Zhu J; Ding Y
J Exp Clin Cancer Res; 2023 Nov; 42(1):297. PubMed ID: 37950281
[TBL] [Abstract][Full Text] [Related]
9. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
10. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
Lin C; Yao E; Chuang PT
Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
[TBL] [Abstract][Full Text] [Related]
11. Protein kinases of the Hippo pathway: regulation and substrates.
Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR
Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666
[TBL] [Abstract][Full Text] [Related]
12. The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes.
St Louis BM; Quagliato SM; Su Y-T; Dyson G; Lee P-C
mBio; 2024 May; 15(5):e0342923. PubMed ID: 38624208
[TBL] [Abstract][Full Text] [Related]
13. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Wong KF; Liu AM; Hong W; Xu Z; Luk JM
Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
[TBL] [Abstract][Full Text] [Related]
14. MAP4K2 connects the Hippo pathway to autophagy in response to energy stress.
Seo G; Mckinley J; Wang W
Autophagy; 2024 Mar; 20(3):704-706. PubMed ID: 37937799
[TBL] [Abstract][Full Text] [Related]
15. STRIPAK integrates upstream signals to initiate the Hippo kinase cascade.
Chen R; Xie R; Meng Z; Ma S; Guan KL
Nat Cell Biol; 2019 Dec; 21(12):1565-1577. PubMed ID: 31792377
[TBL] [Abstract][Full Text] [Related]
16. STRN3 promotes tumour growth in hepatocellular carcinoma by inhibiting the hippo pathway.
Zhu J; Tang W; Fang P; Wang C; Gu M; Yang W; Pan B; Wang B; Guo W
J Cell Mol Med; 2024 Mar; 28(6):e18147. PubMed ID: 38429901
[TBL] [Abstract][Full Text] [Related]
17. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
18. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027
[TBL] [Abstract][Full Text] [Related]
19. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
20. Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.
Sarmasti Emami S; Ge A; Zhang D; Hao Y; Ling M; Rubino R; Nicol CJB; Wang W; Yang X
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
